#regn buy signal @regn buy position @742.2$
Good financial ratios and good indicators level
@intelligent.investing.144
0%
0%
0%
0%
0%
About Regeneron Pharmaceuticals, Inc
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Leonard S. Schleifer
Website
regeneron.com
Headquarters
Tarrytown
Employees
11.851K
Founded
1988
ISIN
US75886F1075
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Nothing yet but wowWhen she goes, OH BABY she'll go.
It's a big flag and $REGN has a lot of positivity behind it. People like the company.
IF POWELL IS GOOD. This may be one of the best reactions.
Just based off of the technical analysis, and what I see on the chart. So pretty.
I don't have the algo on in this on
REGN: stable bullish trendA price action above 754 supports a bullish trend direction.
The ideal entry price is as close to 750 as possible.
Increase the long exposure for a break above 787.50.
The first target price is set at 807.50.
The second target price is set at 863.00.
Stop-loss 731.00
$REGN with a bullish outlook following its earnings #Stocks The PEAD projected a bullish outlook for $REGN after a positive under over reaction following its earnings release placing the stock in drift A with an expected accuracy of 66.67%.
V can C bullish flag pattern breakout very soon in this Pharma.About:-
Regeneron Pharmaceuticals, Inc. is a biotechnology company that discover, invent, develops, manufactures and commercializes medicines for the treatment of serious diseases. The company commercializes medicines and product candidates for eye diseases, allergic and inflammatory diseases, pain,
REGN - Channels Down channel and following up channel
I expect a bullish breakout from the current up channel a continuation from the last move up
This expectation is shown with the bars pattern indicator
Daily timeframe
REGN Regeneron Pharmaceuticals Options Ahead of EarningsLooking at the REGN Regeneron Pharmaceuticals options chain ahead of earnings , I would buy the $730 strike price Puts with
2023-2-17 expiration date for about
$16.53 premium.
If the options turn out to be profitable Before the earnings release, I would sell at least 50%.
Looking forward to read yo
REGNThe Trend Lines are above. If SPX does not decline, all the stocks can start a rally which I expect cannot exceed the ATH. I expect 2024 will be the bigger rally and this year, I expect fluctuations.
Not an investment reccomendation.
RectanglePrice is above the .236 of the trend up.
Bound in a horizontal trading channel for the time being.
Neutral pattern. Some trade inside the rectangle but it will eventually break to one side or the other.
No recommendation.
EPS (FWD)
42.93
PE (FWD)
17.09
Div Rate (TTM)
-
Short Interest
1.52%
Marke
🟩 $REGN - Buying againI am buying $REGN again here.
I like the base, the volume signatures are great and it is showing great strength.
The industry is Biotech (and it is in top 30 industries currently in the stock market)
The IBD RS rating is 95
Fund ownership is increasing:
- notable funds owning it are: American Cen
See all ideas
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Gain new superpowers
Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn moreCurated watchlists where REGN is featured.
